Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

national-cancer-institute-kmvohcb-w5g-unsplash_1

First patient dosed in AdvanCell’s phase 1/2 trial for prostate cancer treatment

November 9, 2023
Research and Development AdvanCell, Cancer, Oncology, clinical trial, prostate cancer

AdvanCell has announced that the first patient has been dosed with 212Pb-ADVC001 in its phase 1/2 trial for the PSMA-positive …

News

GSK shares results from phase 3 RUBY trial of Jemperli for endometrial cancer treatment

October 30, 2023
Medical Communications Cancer, GSK, Jemperli, Oncology, endometrial cancer

GSK has announced positive headline results from an analysis of part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase 3 trial which assessed …

News

Nuvectis Pharma initiates phase 1a NXP900 clinical trial

September 13, 2023
Research and Development Cancer, Nuvectis Pharma, Oncology, clinical trial

Clinical stage biopharmaceutical company Nuvectis Pharma has announced the initiation of a phase 1a dose escalation clinical study of NXP900, …

News

Zumutor’s cancer drug trial cleared by FDA

August 14, 2023
Research and Development Cancer, Oncology, clinical trial, pharmaceutical

On 11 August 2023, the biopharmaceutical company Zumutor Biologics announced that the trial of its ZM008 drug for cancer had …

News

Targeted chemotherapy to kill all solid tumours developed in preclinical research

August 3, 2023
Research and Development Cancer, Oncology, chemotherapy, pharmaceutical, tumour

Researchers from the City of Hope organisation in the US have released a study confirming the development of AOH1996, a …

News
Chemotherapy

EMA accepts Astellas’ MAA for Zolbetuximab

July 14, 2023
Medical Communications Astellas, Cancer, EMA, Oncology, zolbetuximab

Astellas Pharma has announced that the European Medicines Agency (EMA) has accepted the company’s marketing authorisation application (MAA) for regulatory …

News

CellCentric announces $25m investment from Pfizer

July 12, 2023
Business Services Cancer, CellCentric, Oncology, Pfizer, collaboration, investment

UK-based biotechnology company CellCentric has announced a strategic investment from Pfizer including $25m to finance further development of inobrodib, its …

News

Nanobiotix announces license agreement with Janssen for development and commercialisation of new cancer treatment

July 10, 2023
Sales and Marketing Cancer, Janssen, License Agreement, Oncology, nanobiotix

Nanobiotix has announced a global licensing, co-development and commercialisation agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies …

News
national-cancer-institute-kluafqlacfw-unsplash

UK nonprofit National Cancer Research Institute to close

June 27, 2023
Medical Communications Cancer, NCRI, National Cancer Research Institute, Oncology, oncology

The National Cancer Research Institute (NCRI) has announced that it is closing after 22 years of advancing cancer research. Established …

News

XOMA acquires royalty and milestone rights for NPC and pancreatic cancer assets

June 23, 2023
Sales and Marketing Cancer, Oncology, Xoma, acquisition, oncology

US-based biotechnology royalty aggregator XOMA has announced that it has gained the royalty and milestone rights for two assets from …

News
money-pills-pharma-file

GSK settles first Zantac lawsuit due for trial in US

June 23, 2023
Medical Communications Cancer, GSK, Pharmacy, Zantac, lawsuit

UK-based pharmaceutical and biotechnology company GSK has reached a settlement with a US man who claims the drugmaker’s heartburn medicine …

News
clinical_trials

Kymera Therapeutics reports positive data in cancer drug trials

June 14, 2023
Research and Development Cancer, Kymera Therapeutics, Oncology, autoimmune diseases, clinical trials, inflammatory diseases

US clinical-stage biopharmaceutical company Kymera Therapeutics has shared new data regarding its oncology programmes KT-333 and KT-413, highlighting their robust dose-dependent …

News

AstraZeneca and MSD’s Lynparza receives NICE positive recommendation as a cancer maintenance treatment

June 9, 2023
Research and Development AstraZeneca, Cancer, MSD, NICE, Oncology, lynparza, pharma

UK-based pharmaceutical company AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) posted a positive recommendation …

News
blood_tests_pic

Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation

June 8, 2023
Research and Development Cancer, FDA, Haematology, Innate Pharma, Sanofi, haematology

Innate Pharma has announced that the drug jointly researched between itself and Sanofi has received US Food and Drug Administration (FDA) …

News
blood_tests_pic

GRAIL and University of Oxford showcase first prospective study results for multi-cancer early detection test

June 6, 2023
Research and Development Cancer, GRAIL, Oncology, University of Oxford, cancer testing

US-based healthcare company GRAIL and the University of Oxford, UK, have announced encouraging first prospective study results at the American …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026